Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: Design, synthesis, and preclinical characterization - Elokdah, H; Abou-Gharbia, M; Hennan, JK (J Med Chem, 2004)
et al.